BIOMAT Database Logo BIOMAT Database Logo

Iatrogenic Atrial Septal Defect Closure Following Mitral Transcatheter Edge-to-Edge Repair: When Do You Close? 2021

Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Division of Cardiology, Department of Medicine, NorthShore University Healthsystem, Evanston, Illinois, USA.

Transcatheter edge-to-edge repair has revolutionized the management of mitral regurgitation in the high surgical-risk population. Iatrogenic atrial septal defects (iASDs) are an obligatory consequence of the procedure. The long-term sequelae of persistent iASDs are unknown but are believed to be dependent on their size, directionality of flow, and underlying hemodynamics. We discuss an uncommon scenario of a post-transcatheter edge-to-edge repair iASD that required immediate closure. (Level of Difficulty: Intermediate.).

UI MeSH Term Description Entries

Related Publications

Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Iatrogenic Atrial Septal Defect Requiring Transcatheter Closure Following Transcatheter Mitral Valve Repair.
October 2022, Circulation journal : official journal of the Japanese Circulation Society,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
When to close iatrogenic atrial septal defect after percutaneous edge to edge repair of mitral valve regurgitation.
September 2016, Cardiovascular revascularization medicine : including molecular interventions,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Biventricular Physiology of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Edge-to-Edge Repair.
January 2021, JACC. Cardiovascular interventions,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Successful transcatheter closure for lacerated iatrogenic atrial septal defect during transcatheter mitral valve repair using MitraClip.
January 2021, Cardiovascular intervention and therapeutics,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Closure of Iatrogenic Atrial Septal Defect After Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial.
January 2021, Circulation,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair and Implications of Interventional Closure.
December 2021, JACC. Cardiovascular interventions,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Outcomes of Percutaneous Atrial Septal Defect Closure With Mitral Transcatheter Edge-to-Edge Repair and Transseptal Mitral Valve Replacement (2015 to 2020).
October 2023, The American journal of cardiology,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Fate of iatrogenic atrial septal defects following mitral transcatheter edge-to-edge repair - a subanalysis of the MITHRAS trial.
March 2023, The international journal of cardiovascular imaging,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Iatrogenic atrial septal defect does not affect acute hemodynamic modifications after transcatheter edge-to-edge repair in patients with functional mitral regurgitation.
January 2022, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,
Mrinali Shetty, and Mark B Lampert, and Justin Levisay, and John P Erwin, and Mark J Ricciardi
Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
January 2024, International journal of cardiology,
Copied contents to your clipboard!